nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Angiogenesis-Targeted Therapies in Prostate Cancer
|
Lara Jr, Primo N. |
|
2004 |
3 |
3 |
p. 165-173 9 p. |
artikel |
2 |
Beyond PSA: A Need for Additional Markers for Prostate Cancer
|
Sartor, Oliver |
|
2004 |
3 |
3 |
p. 135- 1 p. |
artikel |
3 |
Early Use of Chemotherapy in Conjunction with Radical Prostatectomy
|
Alumkal, Joshi J. |
|
2004 |
3 |
3 |
p. 144-149 6 p. |
artikel |
4 |
Highlights from the 29th European Society for Medical Oncology Congress Vienna, Austria October 29 through November 2, 2004
|
Price, Nancy |
|
2004 |
3 |
3 |
p. 136-140 5 p. |
artikel |
5 |
Measurement of Intracellular Versus Extracellular Prostate-Specific Antigen Levels in Peripheral Macrophages: A New Approach to Noninvasive Diagnosis of Prostate Cancer
|
Herwig, Ralf |
|
2004 |
3 |
3 |
p. 184-188 5 p. |
artikel |
6 |
Molecular Markers and Prostate Cancer Prognosis
|
Chin, Jonathan L. |
|
2004 |
3 |
3 |
p. 157-164 8 p. |
artikel |
7 |
Newer Therapies in Advanced Prostate Cancer
|
Hegeman, Robert B. |
|
2004 |
3 |
3 |
p. 150-156 7 p. |
artikel |
8 |
Phase I/II Trial of Bortezomib plus Docetaxel in Patients with Advanced Androgen-Independent Prostate Cancer
|
Price, Nancy |
|
2004 |
3 |
3 |
p. 141-143 3 p. |
artikel |
9 |
Preliminary Assessment of Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Outcome in Patients with Prostate Cancer at High Risk for Relapse
|
Pucar, Darko |
|
2004 |
3 |
3 |
p. 174-181 8 p. |
artikel |
10 |
Protease-Activated Receptor 1: A Role in Prostate Cancer Metastasis
|
Yuan, Ta-Chun |
|
2004 |
3 |
3 |
p. 189-191 3 p. |
artikel |
11 |
Role of Magnetic Resonance Spectroscopic Imaging in the Prediction of Treatment Outcome in Prostate Cancer
|
Bezabeh, Tedros |
|
2004 |
3 |
3 |
p. 182-183 2 p. |
artikel |